RASopathies: Evolving Concepts in Pathogenetics, Clinical Features, and Management

Area of Science:

• Genetics
• Molecular Biology
• Dermatology

Background:

• RASopathies encompass a spectrum of genetic disorders arising from mutations in the RAS/MAPK pathway, crucial for cell cycle regulation.
• Germline mutations in this pathway lead to overlapping clinical features, with neuroectodermal involvement being a common characteristic.
• Recent findings indicate RASopathies can affect vasculature, lymphatics, and the immune system, alongside emerging evidence of cutaneous mosaic disorders linked to this pathway.

Purpose of the Study:

• To review the pathogenesis of RASopathies with a specific focus on cutaneous manifestations.
• To summarize key diagnostic clues for dermatologists identifying RASopathies.
• To highlight the evolving understanding of genotype-phenotype correlations and therapeutic strategies.

Main Methods:

• Literature review of RASopathies and their genetic basis.
• Analysis of clinical features, particularly dermatological signs.
• Synthesis of current research on pathway pathogenesis and therapeutic advancements.

Main Results:

• RASopathies share common features due to pathway dysregulation, with skin manifestations being significant diagnostic indicators.
• Understanding the molecular pathogenesis provides insights into genotype-phenotype correlations.
• Targeted therapies are under development, showing promise for future patient treatment.

Conclusions:

• RASopathies are complex genetic disorders with diverse manifestations, including significant dermatological findings.
• Dermatologists play a crucial role in diagnosing RASopathies by recognizing specific cutaneous clues.
• Advancements in understanding the RAS/MAPK pathway are paving the way for novel therapeutic interventions.